Variantyx, a startup focused on using precision medicine technology in genomic testing, announced a $41.5 million C-2 funding round. New Era Capital Partners led the round with participation from Peregrine Ventures, Robert Bosch Ventures Capital, 20/20 HealthCare Partners and Pitango HealthTech.
This news comes just under a year after the Massachusetts-based company closed its $20 million Series...